161 related articles for article (PubMed ID: 9532908)
1. [Characteristics of histocompatibility antigens distribution in patients with multiple sclerosis].
Shiralieva RK; Guseĭnova KA
Klin Med (Mosk); 1998; 76(1):19-20. PubMed ID: 9532908
[TBL] [Abstract][Full Text] [Related]
2. [Clinico-immunologic parallels in multiple sclerosis].
Prokof'ev VF; Konenkov VI; Gribacheva IA; Voronova IA; Doronin BM
Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(2):31-4. PubMed ID: 2728717
[TBL] [Abstract][Full Text] [Related]
3. HLA genotypes in Turkish patients with myasthenia gravis: comparison with multiple sclerosis patients on the basis of clinical subtypes and demographic features.
Dönmez B; Ozakbas S; Oktem MA; Gedizlioglu M; Coker I; Genc A; Idiman E
Hum Immunol; 2004 Jul; 65(7):752-7. PubMed ID: 15301866
[TBL] [Abstract][Full Text] [Related]
4. Combined influences of Gm and HLA phenotypes upon multiple sclerosis susceptibility and severity.
Salier JP; Sesboüé R; Martin-Mondière C; Daveau M; Cesaro P; Cavelier B; Coquerel A; Legrand L; Goust JM; Degos JD
J Clin Invest; 1986 Aug; 78(2):533-8. PubMed ID: 3461005
[TBL] [Abstract][Full Text] [Related]
5. HLA-antigen frequencies in patients with progressive systemic sclerosis and morphea.
Kühnl P; Sibrowski W; Kalmar G; Holzmann H; Sollberg S; Böhm BO
Beitr Infusionsther; 1990; 26():287-9. PubMed ID: 1703854
[TBL] [Abstract][Full Text] [Related]
6. [Histocompatibility antigens in multiple sclerosis patients].
Khondkarian OA; Tananov AT; Zavalishin IA; Nevskaia OM; Kut'ina RM
Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(2):7-10. PubMed ID: 7234266
[TBL] [Abstract][Full Text] [Related]
7. Outcome of haematopoietic stem cell transplantation in patients transplanted with matched unrelated donors vs allele-mismatched donors: a single centre study.
Hauzenberger D; Schaffer M; Ringdén O; Hassan Z; Omazic B; Mattsson J; Wikström AC; Remberger M
Tissue Antigens; 2008 Dec; 72(6):549-58. PubMed ID: 19000143
[TBL] [Abstract][Full Text] [Related]
8. [Immunogenetic markers of disseminated sclerosis in western Siberia].
Prokof'ev VF; Gribacheva IA; Konenkov VI; Doronin BM; Voronova IA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(12):49-52. PubMed ID: 3245376
[TBL] [Abstract][Full Text] [Related]
9. [Multiple sclerosis and the histocompatibility system].
Khondkarian OA; Tananov AT; Zavalishin IA; Nevskaia OM
Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(2):167-71. PubMed ID: 6176089
[TBL] [Abstract][Full Text] [Related]
10. Ethnic differences in HLA antigens in Chilean donors and recipients: data from the National Renal Transplantation Program.
Droguett MA; Beltran R; Ardiles R; Raddatz N; Labraña C; Arenas A; Flores J; Alruiz P; Mezzano S; Ardiles L
Transplant Proc; 2008 Nov; 40(9):3247-50. PubMed ID: 19010245
[TBL] [Abstract][Full Text] [Related]
11. [Complement markers Bf and C4 in multiple sclerosis].
Fauchet R; Madigand M; Gueguen-Duchesne MY; Papin J; Sabouraud O; Genetet B
Rev Neurol (Paris); 1984; 140(6-7):422-5. PubMed ID: 6611572
[TBL] [Abstract][Full Text] [Related]
12. [Immunogenetic markers in the course of vibration disease].
Sideltseva EV; Kolesov VG; Aleksev LP; Sideltsev VV
Med Tr Prom Ekol; 1993; (11-12):27-30. PubMed ID: 7921836
[TBL] [Abstract][Full Text] [Related]
13. HLA status in patients with chronic spontaneous urticaria.
Bozek A; Krajewska J; Filipowska B; Polanska J; Rachowska R; Grzanka A; Jarzab J
Int Arch Allergy Immunol; 2010; 153(4):419-23. PubMed ID: 20559009
[TBL] [Abstract][Full Text] [Related]
14. HLA antigens in multiple sclerosis in Alsace.
Rumbach L; Tongio MM; Warter JM; Marescaux C; Grange D; Mayer S; Collard M
Biomed Pharmacother; 1985; 39(7):385-9. PubMed ID: 3830266
[TBL] [Abstract][Full Text] [Related]
15. [HLA-DRW antigens and multiple sclerosis].
De Moerloose PH; Jeannet M; Martins-da-Silva B; Werner-Favre C; Rohr J; Gauthier G
Schweiz Arch Neurol Neurochir Psychiatr; 1978; 123(1):51-61. PubMed ID: 83671
[TBL] [Abstract][Full Text] [Related]
16. [Disseminated sclerosis. Possible correlation between clinical forms and HLA groups (author's transl)].
Madigand M; Fauchet R; Oger J; Sabouraud O
Nouv Presse Med; 1981 Jun; 10(28):2349-52. PubMed ID: 7267340
[TBL] [Abstract][Full Text] [Related]
17. Expression of A, B, C and DR antigens in definite Meniere's disease in a Spanish population.
López-Escámez JA; López-Nevot A; Cortes R; Ramal L; López-Nevot MA
Eur Arch Otorhinolaryngol; 2002 Aug; 259(7):347-50. PubMed ID: 12189399
[TBL] [Abstract][Full Text] [Related]
18. Histocompatibility (HLA) antigens and multiple sclerosis in Israelis.
Brautbar C; Amar A; Cohen I; Kahana E; Cohen T; Bloch D; Grosse-Wilde H; Alter M
Isr J Med Sci; 1982 May; 18(5):631-4. PubMed ID: 7096048
[TBL] [Abstract][Full Text] [Related]
19. Protective role of the HLA-A*02 allele in Portuguese patients with multiple sclerosis.
Silva AM; Bettencourt A; Pereira C; Santos E; Carvalho C; Mendonça D; Costa PP; Monteiro L; Martins B
Mult Scler; 2009 Jun; 15(6):771-4. PubMed ID: 19482867
[TBL] [Abstract][Full Text] [Related]
20. [HLA-A, B, C phenotype frequencies in progressive systemic scleroderma].
Baldauf C; Schaller J; Herrmann K; Haustein UF
Dermatol Monatsschr; 1989; 175(1):16-9. PubMed ID: 2920860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
